Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Cisplatin resistance: preclinical findings and clinical implications.

Köberle B, Tomicic MT, Usanova S, Kaina B.

Biochim Biophys Acta. 2010 Dec;1806(2):172-82. doi: 10.1016/j.bbcan.2010.07.004. Epub 2010 Jul 17. Review.

PMID:
20647037
2.

The role of DNA repair pathways in cisplatin resistant lung cancer.

O'Grady S, Finn SP, Cuffe S, Richard DJ, O'Byrne KJ, Barr MP.

Cancer Treat Rev. 2014 Dec;40(10):1161-70. doi: 10.1016/j.ctrv.2014.10.003. Epub 2014 Oct 18. Review.

PMID:
25458603
3.

Cellular and molecular determinants of cisplatin resistance.

Perez RP.

Eur J Cancer. 1998 Sep;34(10):1535-42. Review.

PMID:
9893624
4.

Transcription factors and drug resistance.

Kohno K, Uchiumi T, Niina I, Wakasugi T, Igarashi T, Momii Y, Yoshida T, Matsuo K, Miyamoto N, Izumi H.

Eur J Cancer. 2005 Nov;41(16):2577-86. Epub 2005 Oct 4. Review.

PMID:
16209921
5.

Cisplatin resistance: a cellular self-defense mechanism resulting from multiple epigenetic and genetic changes.

Shen DW, Pouliot LM, Hall MD, Gottesman MM.

Pharmacol Rev. 2012 Jul;64(3):706-21. doi: 10.1124/pr.111.005637. Epub 2012 Jun 1. Review.

6.

[Advances of DNA damage repair and Cisplatin resistance mechanisms in lung cancer].

Tang C, Yang H, Zhou X.

Zhongguo Fei Ai Za Zhi. 2011 Dec;14(12):960-4. doi: 10.3779/j.issn.1009-3419.2011.12.11. Review. Chinese.

7.

Preclinical perspectives on platinum resistance.

Kelland LR.

Drugs. 2000;59 Suppl 4:1-8; discussion 37-8. Review.

PMID:
10864225
8.

Towards an understanding of the biological basis of response to cisplatin-based chemotherapy in germ-cell tumors.

Mayer F, Honecker F, Looijenga LH, Bokemeyer C.

Ann Oncol. 2003 Jun;14(6):825-32. Review.

PMID:
12796018
9.

Cisplatin is a DNA-damaging antitumour compound triggering multifactorial biochemical responses in cancer cells: importance of apoptotic pathways.

Sedletska Y, Giraud-Panis MJ, Malinge JM.

Curr Med Chem Anticancer Agents. 2005 May;5(3):251-65. Review.

PMID:
15992353
10.

Nucleotide excision repair: why is it not used to predict response to platinum-based chemotherapy?

Bowden NA.

Cancer Lett. 2014 May 1;346(2):163-71. doi: 10.1016/j.canlet.2014.01.005. Epub 2014 Jan 21. Review.

PMID:
24462818
11.

Cisplatin resistance and opportunities for precision medicine.

Amable L.

Pharmacol Res. 2016 Apr;106:27-36. doi: 10.1016/j.phrs.2016.01.001. Epub 2016 Jan 22. Review.

PMID:
26804248
12.

Understanding cisplatin resistance using cellular models.

Stordal B, Davey M.

IUBMB Life. 2007 Nov;59(11):696-9. Review.

13.

Cisplatin resistance in germ cell tumours: models and mechanisms.

Jacobsen C, Honecker F.

Andrology. 2015 Jan;3(1):111-21. doi: 10.1111/andr.299. Epub 2014 Dec 29. Review.

14.

Circumvention of cisplatin resistance in ovarian cancer by combination of cyclosporin A and low-intensity ultrasound.

Yu T, Yang Y, Zhang J, He H, Ren X.

Eur J Pharm Biopharm. 2015 Apr;91:103-10. doi: 10.1016/j.ejpb.2015.02.003. Epub 2015 Feb 7.

PMID:
25668779
15.

Platinum resistance: the role of DNA repair pathways.

Martin LP, Hamilton TC, Schilder RJ.

Clin Cancer Res. 2008 Mar 1;14(5):1291-5. doi: 10.1158/1078-0432.CCR-07-2238. Review.

16.

Molecular basis of cellular response to cisplatin chemotherapy in non-small cell lung cancer (Review).

Wang G, Reed E, Li QQ.

Oncol Rep. 2004 Nov;12(5):955-65. Review.

PMID:
15492778
17.

Insights into mechanisms of cisplatin resistance and potential for its clinical reversal.

Gosland M, Lum B, Schimmelpfennig J, Baker J, Doukas M.

Pharmacotherapy. 1996 Jan-Feb;16(1):16-39. Review.

PMID:
8700790
18.

Resistance mechanisms to cancer chemotherapy.

Redmond KM, Wilson TR, Johnston PG, Longley DB.

Front Biosci. 2008 May 1;13:5138-54. Review.

PMID:
18508576
19.

Elevated pressure, a novel cancer therapeutic tool for sensitizing cisplatin-mediated apoptosis in A549.

Oh S, Kim Y, Kim J, Kwon D, Lee E.

Biochem Biophys Res Commun. 2010 Aug 13;399(1):91-7. doi: 10.1016/j.bbrc.2010.07.047. Epub 2010 Jul 17.

PMID:
20643104
20.

Mechanisms of resistance to cisplatin.

Kartalou M, Essigmann JM.

Mutat Res. 2001 Jul 1;478(1-2):23-43. Review.

PMID:
11406167

Supplemental Content

Support Center